Brief: Gubra And Camurus Enter Into Collaboration And License Agreement

Camurus AB

16/12/2025 10:33

Dec 16 (Reuters) - Gubra A/S GUBRA.CO:

GUBRA AND CAMURUS ENTER INTO A COLLABORATION AND LICENSE AGREEMENT TO DEVELOP A LONG-ACTING TREATMENT FOR HYPOPARATHYROIDISM

UNDER AGREEMENT, CAMURUS WILL DEVELOP AND COMMERCIALIZE PRODUCT AND GUBRA HAS OPTION TO CO-FINANCE PRODUCT THROUGH DEVELOPMENT

GUBRA WILL RECEIVE TIERED ROYALTIES SCALED TO ITS CHOSEN LEVEL OF FINANCIAL PARTICIPATION.

Source text: ID:nMFNbX0S65

Further company coverage: GUBRA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))